Literature DB >> 27585758

Invasive management of acute coronary syndromes.

William S Weintraub1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27585758      PMCID： PMC5621638          DOI： 10.1016/S0140-6736(16)31273-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study.

Authors:  Yariv Gerber; Laura J Rosen; Uri Goldbourt; Yael Benyamini; Yaacov Drory
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

2.  Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials.

Authors:  Anthony A Bavry; Dharam J Kumbhani; Andrew N Rassi; Deepak L Bhatt; Arman T Askari
Journal:  J Am Coll Cardiol       Date:  2006-09-12       Impact factor: 24.094

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.

Authors:  Lars Wallentin; Lars Lindhagen; Elisabet Ärnström; Steen Husted; Magnus Janzon; Søren Paaske Johnsen; Frederic Kontny; Tibor Kempf; Lars-Åke Levin; Bertil Lindahl; Mats Stridsberg; Elisabeth Ståhle; Per Venge; Kai C Wollert; Eva Swahn; Bo Lagerqvist
Journal:  Lancet       Date:  2016-08-29       Impact factor: 79.321

Review 5.  Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.

Authors:  Keith A A Fox; Tim C Clayton; Peter Damman; Stuart J Pocock; Robbert J de Winter; Jan G P Tijssen; Bo Lagerqvist; Lars Wallentin
Journal:  J Am Coll Cardiol       Date:  2010-03-30       Impact factor: 24.094

6.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

7.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.

Authors:  K A A Fox; P A Poole-Wilson; R A Henderson; T C Clayton; D A Chamberlain; T R D Shaw; D J Wheatley; S J Pocock
Journal:  Lancet       Date:  2002-09-07       Impact factor: 79.321

8.  10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized Trial.

Authors:  Robert A Henderson; Christopher Jarvis; Tim Clayton; Stuart J Pocock; Keith A A Fox
Journal:  J Am Coll Cardiol       Date:  2015-08-04       Impact factor: 24.094

Review 9.  Oral dual antiplatelet therapy: what have we learnt from recent trials?

Authors:  Gilles Montalescot; Marc S Sabatine
Journal:  Eur Heart J       Date:  2015-08-06       Impact factor: 29.983

10.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.